US Bone Grafts and Substitutes Market 2019

Complete report is available @ http://www.rnrmarketresearch.com/medipoint-bone-grafts-and-substitutes-us-analysis-and-market-forecasts-market-report.html .Read more on “MediPoint: Bone Grafts and Substitutes – US Analysis and Market Forecasts” report below.

Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the most popular option during bone grafting in the Asia-Pacific (APAC) region and South America.
The majority of the market revenue for BGS is contributed by the US. Medtronic is considered the top player in the US market due to its strength in multiple segments. In the allograft bone space (including both traditional and machined allograft bone segments), Medtronic and MTF were two of the tier one players in 2013. In the BMP/growth factor segment, Medtronic’s dominance is widely considered not replicable despite surgeons’ dampened enthusiasm about its INFUSE Bone Graft.